Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ulrich Mengs"'
Autor:
Ulrich Mengs, Ralf-Torsten Pohl
Publikováno v:
Zeitschrift für Phytotherapie. 34:164-168
Zur Anwendung von Mistelextrakten bei Krebspatienten Die medizinische Anwendung der Mistel ist traditionell. Die Entdeckung der Mistellektine als wirksamkeitsbestimmende Inhaltsstoffe fuhrte dazu, dass das Interesse an ihrem gezielten Einsatz bei Kre
Publikováno v:
Current Pharmaceutical Biotechnology
More than 90% of all fatal mushroom poisonings worldwide are due to amatoxin containing species that grow abundantly in Europe, South Asia, and the Indian subcontinent. Many cases have also been reported in North America. Initial symptoms of abdomina
Autor:
Philipp Wolf, Martin Lucht, Ulrich Mengs, C. Leiber, Ulrich Wetterauer, Ursula Elsässer-Beile
Publikováno v:
Journal of Urology. 174:76-79
Purpose: Adjuvant intravesical immunotherapy with bacillus Calmette-Guerin (BCG) for noninvasive superficial bladder cancer has been shown to decrease tumor recurrence significantly. However, serious local and systemic side effects of this treatment
Publikováno v:
Cancer Letters. 150:171-175
The main active constituents carrying the anti-cancer activities of aqueous mistletoe extracts have recently been identified as the mistletoe lectins (MLs). Although three different isolectins have been isolated from plant extracts, molecular biologi
Publikováno v:
Pharmacology. 47:196-204
The cytochemical effects of laxatives on rat colonic epithelial cells were studied. A total of 32 rats was divided into four groups. Three groups were treated with bisacodyl, picosulfate and sennosides for 12 weeks, and a fourth group served as contr
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 187(8)
More than 80% of patients with breast cancer undergoing postsurgical radiotherapy (RT) will develop radiodermatitis and approximately 10% of these patients show grade 3 lesions. Side effects may reduce the patient’s compliance and can be limiting f
Publikováno v:
Planta medica. 73(14)
Silibinin, the main component of silymarin (a milk thistle extract used for treatment of liver injury), has been shown to inhibit CYP3A4 in human liver microsomes. The present study was conducted to examine whether inhibition of CYP3A4 by silymarin i
Publikováno v:
Integrative cancer therapies. 6(2)
Silymarin, the active extract from milk thistle, has been extensively used in patients with liver disease of different etiology. Although silymarin is a complex of 7 flavonolignans and polyphenols, silibinin is usually regarded as the most active com
Autor:
Kai-Uwe Klein, Holger Muschick, Kristin Gritzko, Bernhard Tewes, Johannes Doehmer, Ulrich Mengs
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 22(3)
Silymarin was assessed for drug-drug interaction by permeability studies with Caco-2 cells, for cytochrome P450 induction with human primary hepatocytes and for cytochrome P450 inhibition with human liver microsomes. Studies with Caco-2 cells reveale
Publikováno v:
Arzneimittel-Forschung. 51(9)
The in vitro antiproliferative activity of an aqueous mistletoe extract (AME) with a defined content of bioactive mistletoe lectin (ML) was tested in 25 human tumor cell lines, including 20 solid and 5 hematological malignancies and 47 human tumor xe